- Home
- IDCC vs AXSM Comparison
IDCC vs AXSM Comparison
Compare IDCC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IDCC | AXSM |
|---|---|---|
| Founded | 1972 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 8.6B |
| IPO Year | 2007 | 2015 |
Fundamental Metrics
Financial Performance| Metric | IDCC | AXSM |
|---|---|---|
| Price | $375.03 | $183.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 17 |
| Target Price | ★ $412.50 | $211.12 |
| AVG Volume (30 Days) | 379.9K | ★ 515.2K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ 11.80 | N/A |
| Revenue | ★ $307,404,000.00 | N/A |
| Revenue This Year | N/A | $58.18 |
| Revenue Next Year | $3.38 | $55.45 |
| P/E Ratio | $30.95 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $181.05 | $96.09 |
| 52 Week High | $412.60 | $191.50 |
Technical Indicators
Market Signals| Indicator | IDCC | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 68.71 | 67.47 |
| Support Level | $350.35 | $178.00 |
| Resistance Level | $382.78 | $184.40 |
| Average True Range (ATR) | 11.47 | 6.18 |
| MACD | 7.55 | 2.29 |
| Stochastic Oscillator | 97.73 | 96.14 |
Price Performance
Historical ComparisonAbout IDCC InterDigital Inc.
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.